Attached files
| file | filename |
|---|---|
| 10-Q/A - 10-Q/A - ORAMED PHARMACEUTICALS INC. | zk1212436.htm |
| EX-4.2 - EXHIBIT 4.2 - ORAMED PHARMACEUTICALS INC. | exhibit_4-2.htm |
| EX-10.1 - EXHIBIT 10.1 - ORAMED PHARMACEUTICALS INC. | exhibit_10-1.htm |
| EX-4.1 - EXHIBIT 4.1 - ORAMED PHARMACEUTICALS INC. | exhibit_4-1.htm |
| EX-31.4 - EXHIBIT 31.4 - ORAMED PHARMACEUTICALS INC. | exhibit_31-4.htm |
Exhibit 31.3
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO RULE 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
I, Nadav Kidron, certify that:
1. I have reviewed this Amendment No. 1 to the quarterly report on Form 10-Q of Oramed Pharmaceuticals Inc.; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
|
Dated: December 27, 2012
|
/s/ Nadav Kidron
|
|||||
|
Nadav Kidron
President and Chief Executive Officer
|